ZHEJIANG INT'L GROUP CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.72 CNY | -0.41% |
|
-3.76% | -13.29% |
| Sales 2022 | 30.62B 4.21B | Sales 2023 | 32.05B 4.41B | Capitalization | 5.86B 805M |
|---|---|---|---|---|---|
| Net income 2022 | 212M 29.15M | Net income 2023 | 489M 67.23M | EV / Sales 2022 | 0.23 x |
| Net Debt 2022 | 1.11B 153M | Net Debt 2023 | 936M 129M | EV / Sales 2023 | 0.21 x |
| P/E ratio 2022 |
17.8
x | P/E ratio 2023 |
10.9
x | Employees | 2,924 |
| Yield 2022 |
1.09% | Yield 2023 |
2.72% | Free-Float | 23.69% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.41% | ||
| 1 week | -3.76% | ||
| Current month | +0.93% | ||
| 1 month | -6.72% | ||
| 3 months | -9.50% | ||
| 6 months | -14.36% | ||
| Current year | -13.29% |
1 week
9.50
9.83
1 month
9.4010.38
Current year
8.3211.73
1 year
8.3215.80
3 years
8.3216.89
5 years
8.3226.33
10 years
8.3236.58
| Managers | Title | Age | Since |
|---|---|---|---|
Yang Wang
CEO | Chief Executive Officer | 43 | 22-07-05 |
Xu Jie Ying
CHM | Chairman | 51 | 18-01-24 |
Rong Fu Fei
BRD | Director/Board Member | 39 | 18-01-18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jun Yu Guo
BRD | Director/Board Member | 50 | 19-08-13 |
Xu Jie Ying
CHM | Chairman | 51 | 18-01-24 |
Rong Fu Fei
BRD | Director/Board Member | 39 | 18-01-18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-02 | 9.72 | -0.41% | 3,089,092 |
| 24-07-01 | 9.76 | +1.35% | 4,418,022 |
| 24-06-28 | 9.63 | +0.21% | 4,065,274 |
| 24-06-27 | 9.61 | -1.54% | 5,464,366 |
| 24-06-26 | 9.76 | -3.37% | 13,997,380 |
End-of-day quote Shenzhen S.E., July 01, 2024
More quotes
ZHEJIANG INT'L GROUP CO., LTD. is a China-based company principally engaged in the wholesale and retail of pharmaceuticals and medical equipment. The Company purchases products from pharmaceutical manufacturers or suppliers, then wholesales them to distributors, medical institutions and pharmacies, or sells them directly to consumers through retail terminals. The Company conducts its businesses in Mainland China.
Sector
Pharmaceuticals
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -13.29% | 698M | |
| +26.32% | 75.86B | |
| -4.23% | 23.51B | |
| +15.24% | 8.76B | |
| +1.47% | 8.31B | |
| -33.21% | 6.66B | |
| +19.11% | 5.45B | |
| +1.72% | 4.05B | |
| -8.73% | 3.8B | |
| -9.28% | 3.33B |
- Stock Market
- Equities
- 000411 Stock
